BRPI0415623A - medicamento, compreendendo um monÈmero de alquil-açúcar redutor para o tratamento dos distúrbios inflamatórios - Google Patents

medicamento, compreendendo um monÈmero de alquil-açúcar redutor para o tratamento dos distúrbios inflamatórios

Info

Publication number
BRPI0415623A
BRPI0415623A BRPI0415623-4A BRPI0415623A BRPI0415623A BR PI0415623 A BRPI0415623 A BR PI0415623A BR PI0415623 A BRPI0415623 A BR PI0415623A BR PI0415623 A BRPI0415623 A BR PI0415623A
Authority
BR
Brazil
Prior art keywords
skin
aging
mucosa
inhibition
applying
Prior art date
Application number
BRPI0415623-4A
Other languages
English (en)
Inventor
Jean-Philippe Houlmont
Isabelle Rico-Lattes
Emile Perez
Pascal Bordat
Original Assignee
Fabre Pierre Dermo Cosmetique
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fabre Pierre Dermo Cosmetique, Centre Nat Rech Scient filed Critical Fabre Pierre Dermo Cosmetique
Publication of BRPI0415623A publication Critical patent/BRPI0415623A/pt
Publication of BRPI0415623B1 publication Critical patent/BRPI0415623B1/pt
Publication of BRPI0415623B8 publication Critical patent/BRPI0415623B8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/02—Monosaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/602—Glycosides, e.g. rutin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical

Abstract

"MEDICAMENTO, COMPREENDENDO UM MONÈMERO DE ALQUIL-AçúCAR REDUTOR PARA O TRATAMENTO DOS DISTúRBIOS INFLAMATóRIOS". A presente invenção se refere a um medicamento que compreende pelo menos um monómero de alquil- açúcar redutor do qual uma função hidroxila é substituída por um radical alcóxi em C~ 2~-C~ 40~, esse medicamento é vantajosamente destinado a regular os mecanismos inflamatórios. O açúcar redutor é vantajosamente escolhido no grupo constituído pela ramnose, pela fucose e pela glicose. Ela se refere também a um método de tratamento cosmético por aplicação tópica de uma composição que compreende pelo menos um monómero de alquil- açúcar redutor, do qual uma função hidroxila é substituída por um radical alcóxi em C~ 2~-C~ 40~.
BRPI0415623A 2003-10-31 2004-10-29 utilização de um monômero de ramnose, bem como métodos de tratamento cosmético BRPI0415623B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0312798 2003-10-31
FR0312798A FR2861729B1 (fr) 2003-10-31 2003-10-31 Monomere d'alkyl-rhamnose ou d'alkyl-fucose, medicament comprenant un monomere d'alkyl-sucre reducteur
PCT/FR2004/002794 WO2005041983A1 (fr) 2003-10-31 2004-10-29 Medicament comprenant un monomere d'alkyl-sucre reducteur pour le traitement des desordres inflammatoires

Publications (3)

Publication Number Publication Date
BRPI0415623A true BRPI0415623A (pt) 2006-12-12
BRPI0415623B1 BRPI0415623B1 (pt) 2018-03-13
BRPI0415623B8 BRPI0415623B8 (pt) 2021-05-25

Family

ID=34429798

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0415623A BRPI0415623B8 (pt) 2003-10-31 2004-10-29 utilização de um monômero de ramnose, bem como métodos de tratamento cosmético

Country Status (13)

Country Link
US (2) US7666847B2 (pt)
EP (2) EP1682158B9 (pt)
JP (2) JP5079331B2 (pt)
AT (1) ATE510544T1 (pt)
BR (1) BRPI0415623B8 (pt)
CA (1) CA2544107C (pt)
DK (1) DK1682158T3 (pt)
ES (1) ES2366908T3 (pt)
FR (1) FR2861729B1 (pt)
PL (1) PL1682158T3 (pt)
PT (1) PT1682158E (pt)
SI (1) SI1682158T1 (pt)
WO (1) WO2005041983A1 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2861729B1 (fr) * 2003-10-31 2006-09-08 Fabre Pierre Dermo Cosmetique Monomere d'alkyl-rhamnose ou d'alkyl-fucose, medicament comprenant un monomere d'alkyl-sucre reducteur
US8921376B2 (en) * 2005-05-20 2014-12-30 Vertex Pharmaceuticals Incorporated Pyrrolopyridines useful as inhibitors of protein kinase
WO2007116012A1 (en) * 2006-04-07 2007-10-18 L'oréal Use of a d- and l-fucose-derived c-glycoside compound as an agent for activating and regulating cutaneous immunity
FR2899474B1 (fr) * 2006-04-07 2008-06-06 Oreal Utilisation de compose c-glycoside derive d- et l-fucose comme agent activateur et regulateur de l'imminite cutanee
FR2902999B1 (fr) 2006-07-03 2012-09-28 Oreal Utilisation de derives c-glycoside a titre d'actif prodesquamant
FR2902996B1 (fr) * 2006-07-03 2008-09-26 Oreal Compositions cosmetiques associant un derive c-glycoside et un derive n-acylaminoamide
FR2903004B1 (fr) * 2006-07-03 2009-07-10 Oreal Utilisation en cosmetique d'un derive c-glycoside en association avec de l'acide ascorbique
FR2903002B1 (fr) * 2006-07-03 2012-08-17 Oreal Composition associant un derive c-glycoside et un polymere emulsionnant
FR2902998B1 (fr) * 2006-07-03 2012-09-21 Oreal Utilisation d'au moins un derive c-glycoside a titre d'agent apaisant
FR2903003B1 (fr) * 2006-07-03 2012-08-17 Oreal Utilisation d'un derive c-glycoside pour ameliorer la fonction barriere de la peau
FR2929510B1 (fr) 2008-04-02 2011-01-21 Lvmh Rech Utilisation d'au moins un glycoside d'alkyle en tant qu'agen qu'agent anti-vieillissement et/ou calmant des peaux sensibles dans des compositions cosmetiques, et methodes de soin cosmetique utilisant les dites compositions.
FR2929509B1 (fr) 2008-04-02 2011-01-21 Lvmh Rech L'utilisation de glycosides d'alkyle ou de melanges de glycosides d'alkyle en tant qu'agents destines a inhiber la croissance microbienne, et compositions contenant lesdits glycosides d'alkyle.
FR3074686B1 (fr) * 2017-12-12 2019-11-15 Societe D'exploitation De Produits Pour Les Industries Chimiques Seppic Nouveaux glyceryl polyrhamnosides, procede pour leur preparation et composition cosmetiques et/ou pharmaceutiques en comprenant
FR3074685B1 (fr) * 2017-12-12 2019-11-22 Societe D'exploitation De Produits Pour Les Industries Chimiques Seppic Nouveaux polyol polyrhamnosides, procede pour leur preparation et composition cosmetiques et/ou pharmaceutiques en comprenant

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2652742B1 (fr) 1989-10-11 1993-10-29 Dominique Vacher Compositions anallergiques cosmetiques et dermo-pharmaceutiques.
DE69430253T2 (de) * 1993-05-17 2002-11-14 Avant Immunotherapeutics Inc Komplement verwandte proteine und kohlenhydrate enthaltende zusammensetzungen und methoden zur herstellung und verwendung dieser zusammensetzungen
US5614615A (en) * 1995-03-21 1997-03-25 The Scripps Research Institute Sialyl Lewis X mimetics incorporating fucopeptides
US5728371A (en) 1996-04-29 1998-03-17 L'oreal, S.A. Skin protection, fragrance enhancing and vitamin delivery composition
US5728372A (en) 1996-04-29 1998-03-17 L'oreal, S.A. Skin protection, fragrance enhancing and vitamin delivery composition
FR2756735B1 (fr) * 1996-12-11 1999-02-26 Thorel Jean Noel Agent d'inhibition de l'expression de la proteine d'adherence icam-1 et compositions cosmetiques et pharmaceutiques le contenant
DE19704693A1 (de) * 1997-02-07 1998-08-13 Henkel Kgaa Hautpflegemittel
FR2768623B1 (fr) 1997-09-22 1999-12-31 Jean Noel Thorel Composition cosmetique et/ou dermatologique a usage topique pour le traitement des peaux grasses
US6414037B1 (en) * 1998-01-09 2002-07-02 Pharmascience Pharmaceutical formulations of resveratrol and methods of use thereof
DE19845271A1 (de) * 1998-10-01 2000-04-06 Beiersdorf Ag Verwendung von Alkylglucosiden zur Stabilisierung von Flavonen, Flavanonen bzw. Flavonoiden, synergistische Gemische aus Flavonen, Flavanonen bzw. Flavonoiden und Alkylglucosiden sowie kosmetische und dermatologische Zubereitungen mit einem Gehalt an solchen Gemischen
FR2813789B1 (fr) 2000-09-11 2003-05-02 Ind E Com De Cosmeticos Natura Nouvelle composition cosmetique ou pharmaceutique comprenant une association de vitamine c et/ou avec un composant fucose, et utilisation de cette association en cosmetique ou pharmacie
WO2002019980A1 (en) 2000-09-11 2002-03-14 Indústria e Comércio de Cosméticos Natura Ltda. Composition of vitamin c and/or vitamin a
US6919464B1 (en) * 2001-03-21 2005-07-19 Dow Agrosciences Llc Synthetic derivatives of 21-butenyl and related spinosyns
JP4776229B2 (ja) * 2002-07-16 2011-09-21 エラン ファーマ インターナショナル，リミティド 安定なナノ粒子活性物質の液体投与組成物
JP3845368B2 (ja) 2002-11-18 2006-11-15 株式会社コーセー 液状化粧料
FR2861729B1 (fr) * 2003-10-31 2006-09-08 Fabre Pierre Dermo Cosmetique Monomere d'alkyl-rhamnose ou d'alkyl-fucose, medicament comprenant un monomere d'alkyl-sucre reducteur

Also Published As

Publication number Publication date
CA2544107A1 (fr) 2005-05-12
JP2007509913A (ja) 2007-04-19
FR2861729B1 (fr) 2006-09-08
BRPI0415623B1 (pt) 2018-03-13
JP2012229226A (ja) 2012-11-22
JP5079331B2 (ja) 2012-11-21
EP1682158B1 (fr) 2011-05-25
WO2005041983A1 (fr) 2005-05-12
US20100069311A1 (en) 2010-03-18
CA2544107C (fr) 2013-05-28
EP2266580A1 (fr) 2010-12-29
JP5642734B2 (ja) 2014-12-17
EP1682158B9 (fr) 2012-04-04
PL1682158T3 (pl) 2011-10-31
US9163049B2 (en) 2015-10-20
PT1682158E (pt) 2011-09-01
ES2366908T3 (es) 2011-10-26
DK1682158T3 (da) 2011-09-12
BRPI0415623B8 (pt) 2021-05-25
SI1682158T1 (sl) 2011-10-28
FR2861729A1 (fr) 2005-05-06
EP2266580B1 (fr) 2014-03-26
EP1682158A1 (fr) 2006-07-26
US7666847B2 (en) 2010-02-23
US20070134187A1 (en) 2007-06-14
ATE510544T1 (de) 2011-06-15

Similar Documents

Publication Publication Date Title
BRPI0415623A (pt) medicamento, compreendendo um monÈmero de alquil-açúcar redutor para o tratamento dos distúrbios inflamatórios
CA2386954C (en) Methods of treating vascular diseases characterized by nitric oxide insufficiency
Sgonc et al. Age-related aspects of cutaneous wound healing: a mini-review
AU2005282468B2 (en) Improved GHB compositions
CA2309717C (en) Treatment of scar tissue using lipoic acid
CA2680843C (en) Pharmaceutical composition for treatment of diabetic complications
HK1048764B (zh) 寡糖醛糖糖酸及其局部應用
ES2353750T3 (es) Oxazolidinonas para una utilización farmaceútica en la patologías cutáneas, las enfermedades autoinmunes, la foto-inmunosupresión y el rechazo de injerto.
DK1248630T3 (da) Anvendelse af et dermatologisk præparat indeholdende oligosaccharider til behandling af hudsygdomme
Seo et al. Anti-aging effect of rice wine in cultured human fibroblasts and keratinocytes
Rasool et al. Inhibition of monosodium urate crystal-induced inflammation by withaferin A
FR3015291A1 (fr) Composition antiprurigineuse
KR20040095201A (ko) 랑게르한스 세포 이동을 억제하기 위한 적어도 1개의옥사졸린을 포함하는 조성물, 및 이의 용도
JP4898089B2 (ja) ランゲルハンス細胞の遊走を阻害するための少なくとも一種のアルカノールアミドを含んでなる組成物およびその使用
US5914340A (en) Leukotriene antagonists useful for treating dermatoses
JP2004292314A (ja) ケラチノサイト増殖抑制剤
Malo et al. Inhibition by auranofin of pharmacologic and antigen-induced contractions of the isolated guinea pig trachea
RU2812708C2 (ru) Применение композиций на основе ингибитора braf для наружного применения для лечения лучевого дерматита
WO2016146843A1 (en) Compositions comprising dihydroquercetin for use in methods for treating herpes
Deykin et al. Aspirin Preferentially Inhibits Arachidonic Acid Metabolism In Collagen Vs. Thrombin-Stimulated Platelets
Nicholson et al. Sex Difference In Platelet Response To Aspirin Treatment
So et al. Sulfuretin Inhibits Ultraviolet B-induced MMP Expression in Human Dermal Fibroblasts
Rasmussen et al. Effect of acetylsalicylic acid on renal function in systemic lupus erythematosus
Buchanan et al. Sex-Related Differences In Aspirin Pharmacokinetics Following IV Injection In Rabbits
정찬권 Antiinflammatory effect of roasted licorice extract on type II collagen-induced arthritis

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: PARA:INT.CI.A61K 31/7004, A61P 29/00

Ipc: A61K 31/7004 (2011.01), A61P 29/00 (2011.01)

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: PAGAR RESTAURACAO.

B08H Application fees: decision cancelled [chapter 8.8 patent gazette]

Free format text: REFRENTE AO DESPACHO 8.6 NA RPI 2275 DE 12/08/2014.

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]
B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 29/10/2004 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 17A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2642 DE 24-08-2021 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.